Genmab A/S - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
GMAB Nasdaq 2836 www.genmab.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Genmab A/S

Genmab Partners with Anthropic to Accelerate Research and Development Through Agentic Artificial Intelligence - Jan 7th, 2026 7:00 am
Genmab to Present at the 44th Annual J.P. Morgan Healthcare Conference - Jan 5th, 2026 5:58 am
Assessing Genmab (CPSE:GMAB) Valuation As Share Price Momentum Shows Signs Of Cooling - Jan 4th, 2026 9:23 pm
Here’s Why Genmab A/S (GMAB) Rose in Q3 - Dec 31st, 2025 6:43 am
Genmab Faces 'Transformative' Year Ahead With Pivotal Trial Readouts, Truist Securities Says - Dec 30th, 2025 9:24 am
Genmab shelves Phase III lung cancer candidate - Dec 30th, 2025 7:03 am
Genmab to discontinue further development of acasunlimab - Dec 30th, 2025 6:20 am
Genmab Portfolio Prioritization Update - Dec 29th, 2025 6:12 am
Moderna Stock Sees Healthy Relative Strength Rating - Dec 26th, 2025 11:48 am
This Cancer-Fighting Biotech Surges Into Buy Zone As Earnings Soar 131% - Dec 26th, 2025 9:07 am
Celldex Therapeutics Stock Gets RS Rating Lift - Dec 22nd, 2025 1:42 pm
Exploring High Growth Tech Stocks Including 3 Global Leaders - Dec 22nd, 2025 2:38 am
Dow Jones Futures Rise; Palantir, GE Lead 12 Stocks In Buy Zones - Dec 21st, 2025 8:29 pm
Pacira BioSciences Stock Earns Technical Rating Upgrade - Dec 16th, 2025 12:09 pm
Catalyst Pharmaceuticals Stock Gets Relative Strength Rating Lift - Dec 15th, 2025 12:59 pm
Does Genmab’s 2025 Rally Match Its DCF and Earnings Valuation Outlook? - Dec 15th, 2025 12:05 am
Dow Jones Futures Rise, Techs Fall; Broadcom Latest AI Giant To Tumble On Earnings - Dec 12th, 2025 6:13 am
Genmab Announces Completion of Tender Offer for Outstanding Common Shares of Merus N.V. and Commencement of Subsequent Offering Period - Dec 11th, 2025 11:36 pm
Genmab to Hold 2025 R&D Update and ASH Data Review Meeting - Dec 11th, 2025 12:00 am
ASH 2025: AbbVie and Genmab’s Epkinly sets new standard in second-line FL - Dec 10th, 2025 10:40 am